Publication | Closed Access
A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150
156
Citations
16
References
2006
Year
Hematological MalignancyNational Cancer InstituteLymphoid NeoplasiaMantle Cell LymphomaMedicineHematologyImmunologyPathologyPhase Ii StudyOncologyRadiation OncologyCancer ResearchMolecular OncologyHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1